Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like we are getting current soon. By the looks of the comments, people are pretty excited.
$NPHC We just received approval to file our 2020 annual report from our auditors. As promised, we're working diligently and doing everything in our power to get current ASAP; completing the first two quarters of 2021 to bring us fully current in the next few weeks. #MS #Nyloxin
— Nutra Pharma (@nutrapharma) September 8, 2021
Good morning sir!
Rik may be starting to understand that it is better to under promise and over deliver, rather than vice versa.
I’m not allowed to speak my mind on here so I will leave it at that. We could discuss off line if you would like.
If it is a secret why would you tell anyone?
I highly doubt anyone thought it was a blue chip stock, it is in the OTC. I’m biting my tongue now so I don’t get thrown back in the slammer thanks to you.
Does anyone know a stock in the OTC that is not a risk? We don’t put our money into these things to accumulate a few percentage points each year until we retire. We want to hit a homerun, and you can sit back and say all the negative things and take personal shots at people, but most of us know the risk versus reward here. The upside is great. I’m 99% sure we are going to get current and the positive news will flow from there and if this thing just gets to a nickel, most people on here will make a shit ton of money. In Texas a shit ton is a lot of money.
I’ve also been told by the genius people on this board that the MS drug has not gone through any trials, but I saw a genius article that says different. Who should I believe???
https://multiplesclerosisnewstoday.com/rpi-78m-multiple-sclerosis/?cn-reloaded=1
The company has completed Phase 1 clinical trials for RPI-78M, but these results have not been published. The company states that the treatment was well-tolerated and aims to move the potential drug to Phase 2 clinical trials soon.
I know, since I was told on this board of genius people, that is no shorting of OTC stocks, but just saying, if you do have a short position, get out while you can. I know, I know there’s no shorting in the OTC…LMAO!
Get your cheapies while you can!!!!
Government contracts…wtf? Sounds like $$$ to me.
We may get to penny before the CE is gone…LMAO
And it’s still up 8%. They must have some good things in the works to overcome all the negative things you speak of.
I feel you anger and disappointment. We have to hang in there and believe the he will do the right thing. People do things in different ways and we may not agree on the route he is taking, but we will all be happy when we get there.
Here’s the response I received from Rik this morning.
We have been very clear as to the plans and direction of the company.
At this point, we are fulfilling on every point of our business plan:
product launches, sales increases, retail rollout, manufacturing expansion,
new patents, etc... We have also hired professional lobbyists to help get
our products into the VA and help garner government support and grants.
The only real issue is our delinquent public financial filings. We stated
back in November that we were dedicated to getting current in our reporting
requirements as quickly as possible. The problem is that we are at the mercy
of our auditors and their timelines. We have certainly shown progress and
have already filed six of the delinquent reports. We expect to get 2Q and 3Q
2020 completed by next week and the rest by the end of August. We will
certainly be current before the SEC 15(c)211 deadline of September 28th.
Once we are current, we can ask the OTC Markets to remove the CE and the
Stop sign from our symbol to open up trading of the stock. We expect to see
much greater appreciation as we get current and as we continue to report on
our progress.
I hope that this is helpful,
Rik
Thanks! Feels good to be back in the Free World. I am on parole so I have to be good.
That being said, if Rik doesn’t respond to the email I just sent him then I may be on the ledge right beside you.
RSI - I feel that way at times, but knowing that Rik is rather frugal, to be nice, I can’t see him spending any money to get any of the previous filings done and continue the social media campaign. I think everything will come together, just maybe not as quick as we want. I mean once we get current and the pieces that are already in place start coming together, we will easily get back over .01 and we all know once we get their that the sky is the limit.
I’m back!!!! I had to be good for 14 straight days. Now I have to be nice from here on out. Rik can and in the past has made some bad decisions, but he is going in the right direction, sometimes takes a step backwards but the right direction. There are risk buying into this stock, but at these prices and what the company has going for them, the risks are worth the potential reward. I’m mean I would get a second loan on my house to invest, but you sink a few thousand in it and it could pay off big time and quickly. I’ve already cashed in a few shares just to recoup my original investment and am still sitting on a pot of gold if this thing catches fire.
Unfortunately, it’s in Rik’s blood to always take the cheap way out. I think we will be ok, but his frugalness or cheap ass ways drives me crazy at times.
Well we know they must have some $$$ to pay for endorsements.
Once we get current then we will move forward swiftly. So much in the pipeline, with just a few road jumps to get over and them smooth sailing.
They put the CE on us and they are still trying to walk down the PPS.
I bet Schwab is wondering why they are getting so many new accounts being opened.
Does anyone know if you can still buy through a Schwann account in the US? If so I will definitely need to get one opened quick to take advantage of these prices.
Seems like some people are trying anything to hold this down, but there are so many GOOD things coming and once we get current, we will not be held back.
Tomorrow should be the continuation of good things.
Good times are right around the corner. $NPHC
Press release!
$NPHC Nutra Pharma announces filing of updated provisional patent in protection of their technology for nerve agent counter-measures: #Nyloxin #RPI-78M #MS https://t.co/qlSNkKFYht
— Nutra Pharma (@nutrapharma) July 23, 2021
COVID
Isn’t that a standard disclaimer for all homeopathic products?
Or maybe 51 days until we are current and this stock bust out big time. 2 sides to every story Budd.
An Emergency Use Authorization (EUA) is a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies, such as the current COVID-19 pandemic. Under an EUA, FDA may allow the use of unapproved medical products, or unapproved uses of approved medical products in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions when certain statutory criteria have been met, including that there are no adequate, approved, and available alternatives. Taking into consideration input from the FDA, manufacturers decide whether and when to submit an EUA request to FDA.
That’s what I thought I heard also!!! Sounds like a someone is crawfishing. LOL…
I thought it was about 58 million, but who’s counting…lol
I can’t believe I used my one post today for a smart ass comment to Sam.
$NPHC Very nice video outlining a recent announcement from the Company on our expanded manufacturing capabilities. More videos to come. #Nyloxin #PetPainAway #MS https://t.co/xft3rHSWr9
— Nutra Pharma (@nutrapharma) June 3, 2021
@nutrapharma @nyloxin why do people continue to take NSAID’s when there is a great alternative? $NPHC https://t.co/p9lqY7TA8P
— Mike (@MikePit52138632) May 28, 2021
Dude, you just proved yourself wrong.
The part the you bolded is if the study is NOT conduct under IND.
If it is conducted under IND then the study still must comport with all relevant FDA regulations as if it were being conducted within the United States.
So that being said the FDA would not have had any reason to inspect or validate any of the Nutra data if it was conducted under IND.